# Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage

> **NCT07338175** · PHASE3 · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 1192 (estimated)

## Conditions studied

- Intracerebral Hemorrhage

## Interventions

- **DRUG:** Minocycline hydrochloride capsules
- **DRUG:** Placebo capsules of Minocycline hydrochloride capsules

## Key facts

- **NCT ID:** NCT07338175
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-02
- **Primary completion:** 2028-06
- **Final completion:** 2028-12
- **Target enrollment:** 1192 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07338175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07338175, "Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07338175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*